HMR 3832
Latest Information Update: 26 Jun 2003
At a glance
- Originator Aventis
- Class Antibacterials; Ketolides
- Mechanism of Action Protein 50S ribosomal subunit inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Bacterial infections
Most Recent Events
- 25 Jan 2001 New profile
- 25 Jan 2001 Preclinical development for Bacterial infections in USA (Unknown route)